Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
. This involves using a novel approach created in our lab, combining in vitro assays and high-throughput screening analytical methods. Preliminary work has already been performed by a PhD student.•Perform large
-
research pushes the boundaries of protein- and DNA-focused biomolecular and bioinformatics research and engineering technologies. CMB educates and trains the next generation of medical biotechnology
-
, internationally-oriented university that conducts fundamental and applied scientific research. It is highly inter- and multidisciplinary focused and strives for international excellence. Eligibility criteria PhD
-
for international excellence. Eligibility criteria PhD in data science-adjacent fields (biostatistics, bioinformatics, computer science, bioengineering, biotechnology) with a strong publication record. Experience
-
sciences, master in bioinformatics with a biology background Occupancy rate 100% Vacancy type Research staff Job description We are looking for a Scientist for the project OPPORTUNITIES FOR GENETIC SELECTION
-
for this life-threatening condition. Position You will work actively on the preparation of a PhD thesis in the field of cardiogenomics, more specifically hereditary aortic aneurysm and dissection. You are eager
-
, the University of Leuven offers a central European location in the vibrant city of Leuven, known for its innovation. Eligibility criteria Essential Requirements: PhD in Bioinformatics, Computational Biology
-
actively on the preparation of a PhD thesis in the field of cardiogenomics, more specifically hereditary aortic aneurysm and dissection. You are eager to take on a challenging PhD project investigating
-
ERC-funded PhD position in molecular genetics: Unravelling the eukaryotic post-transcriptional regulatory code Job description Are you interested in unraveling a central, yet understudied mechanism
-
) at the VIB CMN. We are excited to announce a call for a joint PhD student in our labs to work on a challenging project at the interface of neurodegeneration, genomics, computational and systems biology